Transmissible spongiform encephalopathies
This article was originally published in The Rose Sheet
Executive Summary
FDA advisory committee scheduled to meet April 15-16 to discuss and make recommendations on the safety of tallow and tallow derivatives used in cosmetics, pharmaceuticals and other FDA regulated products. U.S. and global issues on edible and non-edible tallow will also be considered. The European Union recently approved a BSE tallow exemption excluding the ingredient from a ban on the use of specified risk materials derived from sources potentially afflicted with TSE ("The Rose Sheet" March 16, In Brief). On April 16, the committee will discuss gelatin and dura mater products. The meeting will be held at the Holiday Inn, Bethesda, Md...